首页|肝硬化合并肝癌患者与病毒性肝炎肝硬化患者行肝移植术时凝血功能变化的比较

肝硬化合并肝癌患者与病毒性肝炎肝硬化患者行肝移植术时凝血功能变化的比较

扫码查看
目的:比较肝硬化合并肝癌患者和病毒性肝炎肝硬化患者在行肝移植手术中凝血功能的变化,以更好地调控围术期的凝血功能.方法:对实施肝移植术的37例肝硬化合并肝癌患者(肝癌组)和40例病毒性肝炎肝硬化患者(肝硬化组),于麻醉后术前(Ⅰ期)、无肝期开始(Ⅱ期)及新肝期90 min(Ⅲ期),用凝血弹性描记图(TEG)分别测定各期R值、K值、MA值及α角,同时记录手术中各期患者的出血量及血制品用量.结果:Ⅰ期和Ⅱ期中,肝癌组与肝硬化组相比,MA值、α角增大,术中出血量相埘较少,Ⅰ期所需新鲜冰冻血浆量也少于后者(P<0.05);Ⅲ期中,两组患者的凝血功能都有所降低,均出现R值延长、MA值及α角减小,但肝癌组所需新鲜冰冻血浆和红细胞数量要明显少于肝硬化组(P<0.05),并且两组指标分别与各自术前相比,也有显著性差异(P<0.05).结论:肝癌组患者的凝血功能在肝移植术术前、术中均好于肝硬化组;出血量和所需的血制品也要少于肝硬化组.
Comparison of coagulative function between patients with liver cirrhosis and those with cirrhosis complicated with hepatocellular carcinoma receiving liver transplantation
AIM: To compare the coagulative function between patients with cirrhosis complicated with hepatocellular carcinoma (HCC) and patients with liver cirrhosis so as to modulate the perioperative coagulative function more effectively. METHODS: In 37 patients of liver cirrhosis complicated with HCC (group C) and 40 patients with simple liver cirrhosis (group Ⅴ) , who were undergoing liver transplantation, TEG was employed to determine the R, K and MA values and α angle after anesthesia( phase Ⅰ ), anhepatic phase (phase Ⅱ ) and 90 min after neohepatic phase ( phase Ⅲ ). Blood loss and consumption of blood products in the 3 phases were recorded. RESULTS: In phase Ⅰ and Ⅱ, the MA value and a angle of group C were significantly higher than those in group Ⅴ, the blood loss in group C was markedly lower than that in group Ⅴ and the volume of transfused blood products ( FFP) in phase Ⅰ in group C was lower than that in group Ⅴ ( P < 0.05). In phase Ⅲ, the coagulative function in both groups reduced. The R value was higher but MA value and a angle were lower compared with the preoperative values, respectively(P <0.05) but the consumption of blood products of group C was remarkably lower than that in group V(P < 0. 05). CONCLUSION: Compared with those of the patients with simple cirrhosis, the perioperative coagulative function of patients with liver cirrhosis complicated with HCC is better and blood loss and volume of transfused blood products are lower.

liver transplantationliver cirrhosiscarcinomahepatocellularcoagulative function

李沫、徐晨、余灵祥、张培瑞

展开 >

解放军第302医院麻醉科,北京,100039

解放军第302医院肝胆外科,北京,100039

肝移植 肝硬化 癌,肝细胞 凝血功能

2009

第四军医大学学报
第四军医大学

第四军医大学学报

CSTPCDCSCD北大核心
影响因子:0.599
ISSN:1000-2790
年,卷(期):2009.30(2)
  • 4
  • 4